ArticleJournal of the American Heart Association2025
Prevalence of Cardiovascular-Kidney-Metabolic Stages in US Adolescents and Relationship to Social Determinants of Health.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT07465926. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Associations of Early Add-On GLP-1 Receptor Agonist and SGLT2 Inhibitor Therapy With Mortality and Kidney Outcomes in Adults With Obesity and Type 2 Diabetes Across Cardiovascular-Kidney-Metabolic Stages 2-3: A Target-Trial Emulation
Who cites it
9 citing papers in PubMed.
- Implications of updated adult hypertension guidelines for the evaluation and management of pediatric patients with high blood pressure.Pediatric nephrology (Berlin, Germany) · 2026Article
- Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.Current hypertension reports · 2026Review
- Developmental origins and environmental determinants of cardiovascular-kidney-metabolic syndrome: A pediatric precision prevention perspective.Biomedical journal · 2026Review
- Cardiovascular-Kidney-Metabolic (CKM) Syndrome Staging and Relevance to Precision Nutrition.Nutrients · 2026Review
- Cardiovascular-kidney-metabolic syndrome: a comprehensive review of pathophysiology, epidemiology, diagnosis, and management.Cardiovascular diabetology · 2026Review
- A Comprehensive Analysis of the Impact of Nutrient Intakes on the Stages and Mortality of Cardiovascular-Kidney-Metabolic Syndrome.Food science & nutrition · 2026Article
- Dietary antioxidants and mortality in early-stage CKM syndrome: insights from NHANES.Nutrition & metabolism · 2025Article
- Exploring Potential Causality and Molecular Mechanisms between Heart Failure and Renal Failure: Insights from Mendelian Randomization Studies, the MIMIC-IV Database and the Gene Expression Omnibus Database.Journal of vascular research · 2025Article
- Low education and employment status drive cardiometabolic health: a social determinants perspective in Chinese population.Frontiers in public health · 2025Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRisk factors for atherosclerotic cardiovascular disease begin in youth. Knowledge of the prevalence of cardio-kidney-metabolic (CKM) syndrome in adolescents and its risk factors is critical to understanding the cause of atherosclerotic cardiovascular disease risk burden.
methodsWe conducted a cross-sectional analysis of the 2017 to 2020 US National Health and Nutrition Examination Survey data and determined the prevalence of each CKM stage in adolescents aged 12 to 18 years. We then assessed the relationship between the family income-to-poverty ratio, health insurance, routine health care access, food security, health behaviors, and CKM stage. We quantified associations between social factors, behaviors, and CKM stages using generalized linear and logistic models.
resultsOf the 1774 surveyed US adolescents, representing 30 327 145, 56% (95% CI, 52-60) had CKM stage 0, 37% (95% CI, 33-40) had CKM stage 1, and 7% (95% CI, 5-9) had CKM stage 2. According to sex, race, ethnicity, and age-adjusted analyses, a ratio of income-to-poverty level >1.85, having health insurance, and food security were associated with a 32% (odds ratio [OR[, 0.68 [95% CI, 0.52-0.89]), 40% (OR, 0.60 [95% CI, 0.37-0.99]), and 45% (OR, 0.55 [95% CI, 0.41-0.73]) lower odds of CKM stage 1 to 2, respectively. After adjustment for all sociodemographic factors, only food security was associated with 40% lower odds of CKM stage 1 to 2 (OR, 0.60 [95% CI, 0.44-0.82]).
conclusionsIn adolescents, CKM stages 1 to 2 are strongly associated with food insecurity. Improved access to healthy food and policies to address food security may help prevent higher CKM stages beginning in adolescence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.